Seed rounds sectors 2026: proptech, cancer, space and robotics draw checks

Seed rounds sectors 2026 are clustering around proptech, cancer treatments, space and satellite technology, and robotics, according to a Crunchbase News review of about 800 global seed financings. The analysis focused on rounds between $5 million and $10 million, a range Crunchbase framed as closer to conventional seed risk than the megarounds dominating venture headlines.

Crunchbase also identified cybersecurity as a major theme in the same data set, but covered that category separately. The four other clusters point to a familiar pattern in early-stage investing: seed capital is still going into capital-intensive or technically hard markets when investors see large enough outcomes to justify the risk.

What sectors are getting $5M to $10M seed rounds?

Crunchbase highlighted four categories outside cybersecurity: proptech, cancer therapeutics and diagnostics, space and satellite technology, and robotics. A seed round is usually the stage where investors back a company before there is broad proof of repeatable growth, though the line between seed and Series A has shifted as round sizes have grown.

In proptech, the argument starts with market size. McKinsey & Company has estimated that real estate accounts for roughly two-thirds of global net worth. Crunchbase said venture funding to proptech companies totaled just over $10 billion last year, well below earlier highs, but seed investors are backing startups aimed at construction planning, rental operations, building energy use and supply chains.

Crunchbase cited a sample of 15 real estate-related startups that raised seed rounds in the $5 million to $10 million band this year. Examples included Hint, described as an AI-powered home management system, Optiml, which makes software for real estate decarbonization, and Krane, which is building an AI-enabled construction supply chain platform. Crunchbase did not provide revenue, valuation or headcount figures for those companies in the analysis.

Cancer startups are raising at the top of the range

Cancer-focused startups also showed up repeatedly in the data. Crunchbase pointed to National Cancer Institute and CDC figures showing that an estimated 39% of Americans will be diagnosed with cancer during their lives and that cancer is the second-leading cause of death in the U.S., behind heart disease.

Three California companies in the cancer sample raised $10 million, the top end of the range Crunchbase studied. They were Rybodyn, which is working on AI-driven discovery of previously undetected cancer targets, Vivere Oncotherapies, a developer of targeted therapies for solid tumors, and Valius Sciences, which is focused on cancer diagnostics. As with many seed-stage biotech companies, the analysis did not include timelines to clinical proof or commercialization.

Space and satellite technology formed another cluster. Crunchbase described SpaceX’s IPO as the sector’s highest-profile financing event this year, while noting that earlier-stage deals were also getting done. Its sample included nine space-related companies with seed financings between $5 million and $10 million.

Lux Aeterna, which is developing reusable satellites, was the largest fundraiser in that space-tech sample, according to Crunchbase. Other examples included InSpacePropulsion Technologies, focused on in-space propulsion systems, and Constellation Space, which is developing an ML-native operations platform for satellite fleets.

Robotics produced the widest geographic spread among the categories Crunchbase reviewed, with funded startups based across Asia, North America, Europe and Australia. The firm identified 18 robotics companies that met the $5 million to $10 million seed-round filter this year.

Examples included Somnia Lab, which says it is developing “intimacy robots,” Bubble Robotics, a maker of autonomous underwater robots, and Eternal.ag, which is working on robots for greenhouse harvesting. The category’s inclusion is consistent with prior Crunchbase seed-funding reviews, where robotics also appeared as a recurring early-stage theme.

The data does not show that these sectors are new. It shows that investors are still willing to fund small teams pursuing technically difficult markets before later-stage proof is available. In a market where the largest AI and late-stage financings absorb most attention, the $5 million to $10 million seed band remains a useful signal of where venture investors are placing earlier, less proven bets.

This story draws on original reporting from Crunchbase News.